Biohaven Pharmaceutical Holding Company Ltd.
NYSE:BHVN
20.24 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -846.422 | -408.168 | -570.279 | -213.796 | -118.668 | -528.805 | -240.922 | -127.19 |
| Depreciation & Amortization
| 7.855 | 6.912 | 1.386 | 1.393 | 0.072 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | -5.261 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 71.963 | 28.787 | 193.556 | 65.639 | 29.5 | 54.972 | 16.925 | 13.239 |
| Change In Working Capital
| 16.811 | 24.613 | -28.604 | 1.664 | 8.977 | 3.319 | 5.39 | 3.975 |
| Accounts Receivables
| 0 | 0 | 0 | -188.158 | -120.111 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -24.102 | -37.965 | 0 | 0 | 0 |
| Accounts Payables
| 0.71 | 4.874 | 5.928 | 1.025 | 0.222 | 3.319 | 5.39 | 3.975 |
| Other Working Capital
| 16.101 | 19.739 | -34.532 | 212.899 | 166.831 | -3.319 | -5.39 | -3.975 |
| Other Non Cash Items
| 167.34 | 16.131 | 106.252 | 4.521 | 4.162 | 93.183 | 21.466 | 15.161 |
| Operating Cash Flow
| -582.453 | -331.725 | -297.689 | -145.84 | -75.957 | -377.331 | -197.141 | -94.815 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -4.049 | -3.048 | -41.074 | -0.938 | -2.697 | -2.534 | -4.165 | -0.541 |
| Acquisitions Net
| 0 | 0 | -35 | 1.882 | 267.51 | 0 | 0 | 0 |
| Purchases Of Investments
| -745.68 | -194.121 | -263.716 | -193.295 | -319.395 | 0 | -6.375 | -6.627 |
| Sales Maturities Of Investments
| 504.364 | 326.999 | 0 | 221.565 | 94.985 | 0 | 0 | 0 |
| Other Investing Activites
| 0.391 | 0 | -4 | -28.27 | -43.1 | -1.25 | 0 | 0.127 |
| Investing Cash Flow
| -244.974 | 129.83 | -304.79 | 0.944 | -2.697 | -3.784 | -10.54 | -7.041 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 666.165 | 243.225 | 283.804 | 138.052 | 92.242 | 0 | 43.953 | 0 |
| Common Stock Repurchased
| 11.501 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 11.609 | -31.317 | 483.793 | 138.447 | 152.242 | 434.593 | 340.462 | 209.759 |
| Financing Cash Flow
| 677.774 | 211.908 | 767.597 | 138.447 | 152.242 | 434.593 | 340.462 | 209.759 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0.075 | -0.497 | 0.429 | -0.189 | 0.439 | 0 | 0 | 0 |
| Net Change In Cash
| -149.578 | 9.516 | 165.547 | -6.449 | 73.588 | 53.478 | 132.781 | 107.903 |
| Cash At End Of Period
| 102.542 | 252.12 | 242.604 | 77.057 | 83.506 | 317.727 | 264.249 | 131.468 |